Sugavive MV3.3
Sugavive MV3.3 is a triple oral anti-diabetic formulation used for the comprehensive management of Type 2 Diabetes Mellitus.
View Details9 products found
Sugavive MV3.3 is a triple oral anti-diabetic formulation used for the comprehensive management of Type 2 Diabetes Mellitus.
View DetailsZevlin DM1000 is a highly potent, fixed-dose triple combination therapy for adults with Type 2 Diabetes Mellitus (T2DM).
View DetailsZevlin DM is a combination therapy designed for adults with Type 2 Diabetes Mellitus who need multi-pathway glycemic control but require a lower initial dose.
View DetailsZevlin M is a combination oral antidiabetic medication used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
View DetailsSugavive MV2 isa combination, used to treat adults with type 2 diabetes mellitus when diet, exercise, and dual therapy fail to provide adequate glycemic control
View DetailsSugavive MV1 is a combination, used for the treat with type 2 diabetes when diet, exercise, and standard dual therapy are not enough to achieve glycemic target.
View DetailsSugavive M2 used for patients with type 2 diabetes who require more aggressive blood sugar lowering than lower-dose combinations can provide.
View DetailsSugavive M1 used to treat adults with type 2 diabetes when diet, exercise, and Metformin monotherapy are insufficient to achieve glycemic targets.
View DetailsSugavive M0.5 is designed for the gentle initiation of combination therapy in adults with type 2 diabetes mellitus.
View Details